Ultralife (NASDAQ:ULBI) Director Bradford Whitmore Acquires 14,882 Shares

Ultralife Corporation (NASDAQ:ULBIGet Free Report) Director Bradford Whitmore bought 14,882 shares of the business’s stock in a transaction that occurred on Monday, December 15th. The shares were bought at an average cost of $5.66 per share, for a total transaction of $84,232.12. Following the transaction, the director owned 1,207,043 shares of the company’s stock, valued at $6,831,863.38. The trade was a 1.25% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Ultralife Trading Up 0.7%

NASDAQ ULBI opened at $5.79 on Wednesday. The company has a current ratio of 2.99, a quick ratio of 1.42 and a debt-to-equity ratio of 0.34. The business has a fifty day simple moving average of $6.17 and a 200 day simple moving average of $7.11. Ultralife Corporation has a 12 month low of $4.07 and a 12 month high of $9.52. The firm has a market capitalization of $96.40 million, a P/E ratio of 57.90 and a beta of 0.88.

Ultralife (NASDAQ:ULBIGet Free Report) last posted its quarterly earnings data on Monday, November 17th. The technology company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.28). The firm had revenue of $43.37 million for the quarter, compared to analysts’ expectations of $53.00 million. Ultralife had a return on equity of 1.66% and a net margin of 0.92%.

Institutional Trading of Ultralife

Several hedge funds have recently added to or reduced their stakes in ULBI. Lazard Asset Management LLC boosted its stake in Ultralife by 1,650.0% in the second quarter. Lazard Asset Management LLC now owns 5,565 shares of the technology company’s stock valued at $49,000 after acquiring an additional 5,247 shares during the last quarter. Prelude Capital Management LLC purchased a new stake in shares of Ultralife during the 3rd quarter worth approximately $71,000. Jones Financial Companies Lllp raised its holdings in shares of Ultralife by 1,428.7% in the 1st quarter. Jones Financial Companies Lllp now owns 15,287 shares of the technology company’s stock worth $82,000 after purchasing an additional 14,287 shares during the period. Bank of America Corp DE lifted its stake in Ultralife by 30.7% in the fourth quarter. Bank of America Corp DE now owns 12,067 shares of the technology company’s stock valued at $90,000 after purchasing an additional 2,836 shares during the last quarter. Finally, Squarepoint Ops LLC purchased a new position in Ultralife in the third quarter valued at approximately $109,000. Institutional investors own 30.68% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ULBI. Wall Street Zen downgraded shares of Ultralife from a “strong-buy” rating to a “hold” rating in a research report on Saturday, September 13th. Weiss Ratings restated a “sell (d+)” rating on shares of Ultralife in a research note on Monday. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.

Read Our Latest Analysis on Ultralife

About Ultralife

(Get Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Read More

Insider Buying and Selling by Quarter for Ultralife (NASDAQ:ULBI)

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.